Anne Lesage
CIK: 0001973705
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Pharvaris N.V.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Sep 17, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect20K shares at avg. $38.27$765K - Sep 10, 2026PHVS
Pharvaris N.V.
Sale(S)Direct30K shares at avg. $38.30$1.1M - Sep 10, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct30K shares at avg. $8.05$242K - Jun 30, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct24.9K shares at avg. $8.05$200K - Jun 30, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect30.7K shares at avg. $35.49$1.1M - Jun 30, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct3K shares at avg. $2.59$8K - Jun 30, 2026PHVS
Pharvaris N.V.
Sale(S)Direct27.9K shares at avg. $35.48$989K - Jun 29, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct900 shares at avg. $8.05$7K - Jun 29, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect7K shares at avg. $35.05$245K - Jun 29, 2026PHVS
Pharvaris N.V.
Sale(S)Direct8.3K shares at avg. $35.05$291K - Jun 29, 2026PHVS
Pharvaris N.V.
Sale(S)Direct2.3K shares at avg. $35.12$81K - Jun 29, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct4.2K shares at avg. $8.05$34K - Jun 29, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct4.1K shares at avg. $2.59$11K - Jun 29, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct1.4K shares at avg. $2.59$4K - Jun 25, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct900 shares at avg. $8.05$7K - Jun 25, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct1.4K shares at avg. $2.59$4K - Jun 25, 2026PHVS
Pharvaris N.V.
Sale(S)Direct2.3K shares at avg. $35.12$81K - Jun 25, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect2.3K shares at avg. $35.12$81K - Apr 30, 2026PHVS
Pharvaris N.V.
Sale(S)Direct3.7K shares at avg. $30.26$112K - Apr 30, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct3.7K shares at avg. $2.59$10K - Apr 30, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect19.2K shares at avg. $30.26$581K - Apr 30, 2026PHVS
Pharvaris N.V.
Sale(S)Direct18K shares at avg. $30.26$545K - Apr 30, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct18K shares at avg. $8.05$145K - Apr 29, 2026PHVS
Pharvaris N.V.
Sale(S)Direct3.7K shares at avg. $30.08$111K - Apr 29, 2026PHVS
Pharvaris N.V.
Sale(S)Indirect3.7K shares at avg. $30.06$111K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 | PHVS Pharvaris N.V. | Sale(S) | 20,000 | $38.27 | $765,466 | Indirect |
| Sep 10, 2026 | PHVS Pharvaris N.V. | Sale(S) | 30,000 | $38.30 | $1,149,084 | Direct |
| Sep 10, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 30,000 | $8.05 | $241,500 | Direct |
| Jun 30, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 24,900 | $8.05 | $200,445 | Direct |
| Jun 30, 2026 | PHVS Pharvaris N.V. | Sale(S) | 30,703 | $35.49 | $1,089,637 | Indirect |
| Jun 30, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 2,972 | $2.59 | $7,697 | Direct |
| Jun 30, 2026 | PHVS Pharvaris N.V. | Sale(S) | 27,872 | $35.48 | $988,890 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 900 | $8.05 | $7,245 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Sale(S) | 6,997 | $35.05 | $245,232 | Indirect |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Sale(S) | 8,300 | $35.05 | $290,908 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Sale(S) | 2,300 | $35.12 | $80,786 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 4,200 | $8.05 | $33,810 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 4,100 | $2.59 | $10,619 | Direct |
| Jun 29, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 1,400 | $2.59 | $3,626 | Direct |
| Jun 25, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 900 | $8.05 | $7,245 | Direct |
| Jun 25, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 1,400 | $2.59 | $3,626 | Direct |
| Jun 25, 2026 | PHVS Pharvaris N.V. | Sale(S) | 2,300 | $35.12 | $80,775 | Direct |
| Jun 25, 2026 | PHVS Pharvaris N.V. | Sale(S) | 2,300 | $35.12 | $80,786 | Indirect |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Sale(S) | 3,700 | $30.26 | $111,946 | Direct |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 3,700 | $2.59 | $9,583 | Direct |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Sale(S) | 19,200 | $30.26 | $580,909 | Indirect |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Sale(S) | 18,000 | $30.26 | $544,604 | Direct |
| Apr 30, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 18,000 | $8.05 | $144,900 | Direct |
| Apr 29, 2026 | PHVS Pharvaris N.V. | Sale(S) | 3,700 | $30.08 | $111,280 | Direct |
| Apr 29, 2026 | PHVS Pharvaris N.V. | Sale(S) | 3,700 | $30.06 | $111,229 | Indirect |
1-25 of 34 transactions
About Lesage Anne
Lesage Anne (SEC CIK 0001973705) files insider reports with the SEC as Chief Early Development of Pharvaris N.V. (PHVS).
Signal8 holds 7 ownership filings by Lesage Anne (1 Form 3, 6 Form 4), filed between Mar 18, 2026 and Sep 21, 2026. Those filings report 34 transactions, from Apr 22, 2026 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lesage Anne's filings is in LEXINGTON, MA.
Recent filings by Lesage Anne
- Sep 17, 2026: Open-market sale of PHVS shares (Form 4, code S).
- Sep 10, 2026: Open-market sale of PHVS shares (Form 4, code S).
- Sep 10, 2026: Option exercise of PHVS shares (Form 4, code M).
- Jun 30, 2026: Option exercise of PHVS shares (Form 4, code M).
- Jun 30, 2026: Open-market sale of PHVS shares (Form 4, code S).
Other insiders filing for Pharvaris N.V. (PHVS)
- Lu Peng, President
- Monges Viviane, Director
- Schikan Johannes Gerardus Christiaan Petrus, Director
- Nassif David W., CFO / CLO
- Bjork Elisabeth, Director
- Glassman Robert, Director